Annual report pursuant to Section 13 and 15(d)

Document And Entity Information

Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2021
Mar. 23, 2022
Jun. 30, 2021
Document Information Line Items      
Entity Registrant Name ADIAL PHARMACEUTICALS, INC.    
Trading Symbol ADIL    
Document Type 10-K    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   23,718,962  
Entity Public Float     $ 40,504,498
Amendment Flag false    
Entity Central Index Key 0001513525    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Well-known Seasoned Issuer No    
Document Period End Date Dec. 31, 2021    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Shell Company false    
Entity Ex Transition Period false    
ICFR Auditor Attestation Flag false    
Document Annual Report true    
Document Transition Report false    
Entity File Number 001-38323    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 82-3074668    
Entity Address, Address Line One 1180 Seminole Trail    
Entity Address, Address Line Two Suite 495    
Entity Address, City or Town Charlottesville    
Entity Address, State or Province VA    
Entity Address, Postal Zip Code 22901    
City Area Code (434)    
Local Phone Number 422-9800    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Security Exchange Name NASDAQ    
Entity Interactive Data Current Yes    
Auditor Firm ID 711    
Auditor Name Friedman LLP    
Auditor Location Marlton, New Jersey